- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Kathy Lynn Poppitt
News 8 results
Recognition
June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide
Recognition
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Report on Medicare Compliance
December 5, 2022
Kathy Poppitt comments on the CMS’s Nov. 28 memo on workplace violence in hospitals
Recognition
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
Events 6 results
Webinar
February 28, 2017
Now Presenting in the ED: An EMTALA Update and Discussion of the Rise of the Freestanding ED
Conference
December 2, 2016
2016 Houston Healthcare Roundtable: Be in the Know — 2016 Healthcare Updates You Shouldn't Miss
Conference
October 26, 2016
Fraud and Abuse Update: The Impact of the Supreme Court's Decision In Escobar on Healthcare Providers’ Potential Liability
Conference
September 8, 2016
The Conundrum of Medicinal Marijuana: Implications for Healthcare Providers and Pharmaceutical Companies
Insights 3 results
Client Alert
December 17, 2018
What Next for the ACA after Texas v. U.S.? What the Industry Needs to Know While the Case Is on Appeal
Thought Leadership
November 21, 2016
King & Spalding Sponsors ABA’s 14th Annual Washington Health Law Summit
Newsletter
January 5, 2015
Health Headlines – January 5, 2015